Food and drug administration (FDA) center for drug evaluation and research (cder) risk evaluation and mitigation strategies (rems) integration pilot (start) project COR: samuel carter
Ended Awarded Last action
- Contract number
- 75F40123F80264
- Awardee
-
The Mitre Corporation UEI DMHDNDCPWUD1 Part of The Mitre Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,799,624
Award facts
- Contract value 100% obligated
- $1,799,624.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Original award | $1,799,624 |
About this award
The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) awarded a $1,799,624.00 cost-plus-fixed-fee delivery order contract to The Mitre Corporation, a non-profit organization, to support the Risk Evaluation and Mitigation Strategies (REMS) Integration Pilot (START) project. This contract does not have a set-aside designation. The Mitre Corporation will provide scientific, technical, and acquisition support services to the FDA to assist with this healthcare initiative. The contract has a completion date of September 29, 2024. As a federally funded research and development center (FFRDC), the Mitre Corporation leverages its expertise in areas such as systems engineering, cybersecurity, and data analytics to support government agencies across various domains, including national security and healthcare.
Quick answers
Who was awarded contract 75F40123F80264?
75F40123F80264 was awarded to The Mitre Corporation by Food and Drug Administration (Department of Health and Human Services) on August 14, 2023.
How much is contract 75F40123F80264 worth?
The government has obligated $1,799,624 on 75F40123F80264.
Is contract 75F40123F80264 an order under another contract?
Yes. 75F40123F80264 is a delivery order under 75FCMC18D0047, an indefinite delivery contract.
Was contract 75F40123F80264 competed?
The extent of competition for 75F40123F80264 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award